Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Niagen Bioscience (NAGE) Beginning Cash Balance: 2011-2012

Historic Beginning Cash Balance for Niagen Bioscience (NAGE) over the last 2 years, with Dec 2012 value amounting to $420,152.

  • Niagen Bioscience's Beginning Cash Balance rose 2664.25% to $45.4 million in Q1 2018 from the same period last year, while for Mar 2018 it was $52.6 million, marking a year-over-year increase of 546.61%. This contributed to the annual value of $420,152 for FY2012, which is 81.13% down from last year.
  • As of FY2012, Niagen Bioscience's Beginning Cash Balance stood at $420,152, which was down 81.13% from $2.2 million recorded in FY2011.
  • Niagen Bioscience's Beginning Cash Balance's 5-year high stood at $2.2 million during FY2011, with a 5-year trough of $420,152 in FY2012.
  • Its 2-year average for Beginning Cash Balance is $1.3 million, with a median of $1.3 million in 2011.
  • Data for Niagen Bioscience's Beginning Cash Balance shows a maximum YoY slumped of 81.13% (in 2012) over the last 5 years.
  • Yearly analysis of 2 years shows Niagen Bioscience's Beginning Cash Balance stood at $2.2 million in 2011, then plummeted by 81.13% to $420,152 in 2012.